Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/18/13 → 7/18/16 |
Funding
- PRA Health Sciences (Protocol # B5301001 // Protocol # B5301001)
- Pfizer Inc. (Protocol # B5301001 // Protocol # B5301001)
Prot # B5301001: A Phase 2, Randomized, Double-Blind, Within-Subject, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PF-06473871 in Reducing Hypertrophic Skin Scarring
- Galiano, Robert D (PD/PI)
Project: Research project